SBU News
SBU News > Long Island > Congressman Zeldin Tours LIHTI during Congressional Recess         

Congressman Zeldin Tours LIHTI during Congressional Recess         

Rep. Zeldin touring the laboratory of Vascular Simulations.
Left to right: LIHTI Executive Director and Chief Operating Officer Matthew Stadler, Rep. Lee Zeldin, Senior Vice President of Research Richard Reeder, and Associate Vice President for Technology Partnerships Peter Donnelly.
Left to right: LIHTI Executive Director and Chief Operating Officer Matthew Stadler, Rep. Lee Zeldin, Senior Vice President of Research Richard Reeder, and Associate Vice President for Technology Partnerships Peter Donnelly.

During the 2019 Congressional recess, Congressman Lee Zeldin toured the Long Island High Tech Incubator (LIHTI) located on Stony Brook University’s (SBU) campus. SBU’s Senior Vice President of Research Richard Reeder, Associate Vice President for Technology Partnerships Peter Donnelly, and LIHTI Executive Director and Chief Operating Officer Matthew Stadler greeted the Congressman and provided an update on how Stony Brook University is working with high-tech startup companies to develop groundbreaking research, create thousands of jobs, and generate billions of dollars in positive economic impact for the region.

“LIHTI is a great example of how the support and research expertise of Stony Brook University can help lead to commercial successes,” said Dr. Reeder. “The University plays a valuable role beyond basic science research and education by helping move technologies from the laboratory out into the local and global economy.”

Rep. Zeldin touring the laboratory of Vascular Simulations.
Rep. Zeldin touring the laboratory of Vascular Simulations.

During the tour, Congressman Zeldin observed the work of LIHTI companies first hand, meeting with the CEO of Vascular Simulations Craig Neita and his staff in their laboratory and production facilities. Every year in the U.S. alone, 1 million animals are subject to reliance testing, and 92% of successful animal experimentation ends up failing in human trials. This disparity is one reason modern medicine needs a more representative testing platform that provides accurate feedback within the device research process. With this exact goal in mind, medical technology company Vascular Simulations released Replicator PRO™, a realistic vascular replication system. A better alternative to device reliance animal testing, Replicator Pro™ empowers device development, demonstration, and training for engineers, educators, and physicians.

Additionally, Congressman Zeldin visited the lab of Biocogent, where Founder, President and CEO Joseph Ceccoli explained how Biocogent effectively uses LIHTI resources to provide unique high technology products and services to the personal care and cosmetic industries.

Biocogent President and CEO Joseph Ceccoli explains Biocogent's production operation to Rep. Lee Zeldin. 
Biocogent President and CEO Joseph Ceccoli explains Biocogent’s production operation to Rep. Lee Zeldin.

SBU’s Office of Government Relations worked with LIHTI leadership and SBU Research to coordinate the Congressman’s visit.

Add comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Archives

SBU on Instagram